Plunkett Research Online: Med Biogene, Inc.

MED BIOGENE, INC. (MBI:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Med Biogene Inc is a Canada based life science company. It is primarily focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test .....



Med Biogene, Inc.
Ticker: MBI
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 827-5100
Fax: 1 604 827-5120
Address: 598 East Kent Avenue South
Vancouver, BC V5X 4V6 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs)
ContactsDescription
Ibrahim GhobrialCFO
Iain Weir-JonesChairman of the Board/Director/CEO
See More
Med Biogene Inc is a Canada based life science company. It is primarily focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test .....See More See More

Auditor: PricewaterhouseCoopers LLP.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: